NBSE

- · NASDAQ

Sector -
Industry -
Website neubasetherapeutics.com
Employees(FY) 37
ISIN -

Performance

-3.2%

1W

-5.97%

1M

-45.3%

3M

-42.63%

6M

-48.93%

YTD

-90.25%

1Y

Profile

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of NBSE 2024-05-10

Overview:

In analyzing the technical indicators for NBSE stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potent...

See more ...

Recent News & Updates

2024-05-05 19:28
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-04-05 04:05
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq(Globenewswire)
2024-03-25 21:08
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?(Investorplace)
2023-11-26 20:00
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance(Globenewswire)
2023-09-07 19:00
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder(Yahoo Finance)
2023-09-05 22:00
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE(Yahoo Finance)
2023-08-02 19:00
NeuBase Therapeutics to Explore Strategic Alternatives(Yahoo Finance)
2023-06-30 04:05
NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules(Yahoo Finance)
2023-06-28 20:30
NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors are Non-Immunogenic, Opening the Door to Redosing(Yahoo Finance)
2023-06-28 02:17
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules(Yahoo Finance)
2023-06-13 20:30
NeuBase Announces 1-for-20 Reverse Stock Split(Yahoo Finance)
2023-05-23 20:00
NeuBase to Participate in Jefferies Healthcare Conference(Yahoo Finance)
2023-05-21 19:00
NeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors(Yahoo Finance)
2023-05-16 04:01
NeuBase Announces Formation of Gene Editing Advisory Board(Yahoo Finance)
2023-05-11 04:15
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023(Yahoo Finance)
2023-05-02 05:00
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting(Yahoo Finance)
2023-02-14 03:10
NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023(Yahoo Finance)
2022-12-29 04:53
NeuBase Therapeutics selling stake in company to New York investment firm Alumni Capital(Yahoo Finance)
2022-12-20 19:00
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022(Yahoo Finance)
2022-10-20 20:00
NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company(Yahoo Finance)
2022-10-14 04:05
NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing(Yahoo Finance)
2022-09-22 04:05
NeuBase to Participate at Chardans 6th Annual Genetic Medicines Conference(Yahoo Finance)
2022-08-10 20:00
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022(Yahoo Finance)
2022-08-07 21:57
We Think NeuBase Therapeutics (NASDAQ:NBSE) Needs To Drive Business Growth Carefully(Yahoo Finance)
2022-06-28 20:01
NeuBase Therapeutics Announces Promotion of Dr. William Mann to President and COO(Yahoo Finance)
2022-05-31 19:00
NeuBase to Participate at the Jefferies Healthcare Conference(Yahoo Finance)
2022-05-16 19:00
NeuBase Presents New Preclinical Data at ASGCT 2022 for Its DM1 Program Demonstrating Wide Tissue Distribution and Supporting a Differentiated Whole-Body Treatment Solution(Yahoo Finance)
2022-05-12 05:00
NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022(Yahoo Finance)
2022-05-11 22:53
Insiders who bought in the last 12 months lose an additional US$65k as NeuBase Therapeutics, Inc. (NASDAQ:NBSE) drops to US$29m(Yahoo Finance)
2022-05-02 04:30
NeuBase Therapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting(Yahoo Finance)

Page 1 of 4

previousnext